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The production of a number of polypeptide mediators or lymphokines underlies many of the differentiated functions of T lymphocytes including their
capacity to influence B cells, macrophages, killer cells, as well as a variety of
nonleukocytes. Lympbokine release begins when T cells are stimulated with
antigen or mitogen. It quickly ceases when the stimulant is removed. A primary
control is at tbe level of gene transcription. The stimulation of resting T cells,
or the restimulation of isolated lymphoblasts and T cell lines, induces the
formation of active lymphokine mRNA (1-5).
Evidence that lymphokine mRNA levels are subject to distinct controls has
come fi'om studies of the immunosuppressive drug, cyclosporin A (CsA)J This
cyclic peptide blocks the production of several lymphokines but has minimal
effects on the expression and function of the T cell's receptor for growth factor
or 1L-2 (IL-2-R) (1, 3). Several recent studies (1-4) indicate that the mechanism
of action of CsA is to inhibit the synthesis of lymphokine mRNA that is initiated
upon addition of mitogens. CsA blocks the production of IL-2 mRNA as assessed
by nuclear transcription and northern blotting assays, as well as the mRNAs for
several other lymphokines (IFN-3,, B cell-, and cytolytic T cell-stimulating
factors) as shown with oocyte translation systems (1-4). Another control of
lymphokine mRNA appears to be an endogenous protein, which in some way
downregulates the level of IL-2 message (6, 7).
We have used DNA-RNA blotting to further analyze the control oflymphokine
mRNA levels. The initial goal was to use a large panel of DNA probes to compare
lymphokine and nonlymphokine gene expression in terms of kinetics, mitogen
requirements, and sensitivity to CsA. The probes identified the mRNAs for the
protooncogenes c-fos, c-myb, and c-myc, the IL-2-R, the lymphokines IL-2 and
IFN, and the 70 kD heat shock protein (HSP). The results show that lymphokine
and nonlymphokine mRNAs are induced by distinct exogenous stimuli. However,
IL-2 and IFN mRNAs share with c-myc certain intracellular controls, including
kinetics of mRNA accumulation and sensitivity to CsA.
This work was supported by grant CA 30198 from the National Institutes of Health, Bethesda, MD.
~Abbreviations used in this paper: CsA, cyclosporine A; CX, cycloheximide; HSP, heat shock
protein.
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Materials a n d M e t h o d s
We purchased leukocyte-rich huffy coats from the New York Blood Center;
con A, (crystallized three times) from Miles Laboratories Inc., Elkart, IN; PMA and
cycloheximide (CX) from Sigma Chemical Co., St. Louis, MO; PHA from Gibco, Grand
Island, NY; OKT3 mAb from Ortho Diagnostics, Raritan, NJ. We were generously
supplied with: CsA and CsH by Drs. J. F. Borel and B. Ryffel, Sandoz Pharmaceutical,
Basel, Switzerland; purified rIL-2 (1.2 X 106 U/rag) by Dr. S. Rudnick, Biogen, Cambridge, MA; and several DNA probes. Dr. P. Barr (Chiron Corp., Emeryville, CA)
provided oligonucleotide probes to IL-2 and IFN-~,. The IL-2 probe was complementary
to the 5' region of the IL-2 leader sequence 5'-ATG TAC AGG ATG CAA CTC CTG
T C T TGC-3', and the IFN probe complementary to the 3'-untranslated region of
sequence 5'-CTG TAC CCA AAT GGA AAG TAA CTC A T T T G T TAA AAT TATC3'. Alternatively, an IL-2 cDNA, described by Clark et al. (8) was used. cDNA probes for
c-fos (9), c-myc (10), c-myb (1 I), and IL-2-R (12) were provided by Drs. H. Hanafusa, The
Rockefeller University, K. B. Marcu, State University of New York, Stony Brook, NY,
Dr. J. M. Bishop, University of California, San Francisco, CA, and Dr. W. Greene,
National Institutes of Health, Bethesda, MD, respectively. The origin and specificity of
the cDNAs for fl-actin and/3~-microglobulin, have been described (13, 14), and a description of the 70 kD HSP (HSP-70) is in preparation (L. Andrus).
Cell Cultures. Blood mononuclear cells were obtained by applying 10 ml of buffy coat
preparations to 10 ml Ficoll-Hypaque (Pharmacia Fine Chemicals, Piscataway, NJ). For
studies of unprimed T cells, mononuclear populations were cultured at 5 x 106 cells/ml
in complete medium consisting of RPMI-1640 (Gibco) supplemented with 2% heatinactivated FCS (Sterile Systems, Logan, UT), 20 #g/ml gentamicin sulfate, 5 X 10-5 M
2-ME, and different mitogens: PMA at 10 ng/ml, and PHA at 1 /~g/ml. For studies of
lymphoblasts, we cultured cells at 106 cells/ml for 4-5 d in PHA (1 •g/ml). The cells were
collected, washed, counted and plated at 2 x 10~ cells/ml in RPMI supplemented with
2% serum to which different stimulants or inhibitors (CsA; CX) were added (see Results).
To separate CD4 and CD8 subsets, stimulated nylon wool-nonadherent T cells were
coated with OKT4 or OKT8 hybridoma culture supernatant (American Type Culture
Collection, Rockville, MD) and centrifuged onto Petri dishes coated with anti-mouse Ig
(Jackson Immunochemicals, Avondale, PA). The nonadherent cells were examined by
indirect immunofluorescence and found to be depleted of the T cells that were reactive
with the panning mAb, and to be highly (>95%) enriched in the reciprocal T4 + or T8 +
subset. In most experiments, the mitogens and CsA were applied continuously, but in
experiments in which lymphokine release was measured, these agents were applied as a 2h pulse in serum-free medium. Most cells attached to the dishes in the absence of serum.
The mitogens and CsA were removed by washing and the attached cells recultured in
medium (above).
RNA Blot (Northern) Analysis. Total cellular RNA was isolated by a guanidine isothiocyanate method (15) with cesium chloride modification (16), and quantified by absorbance
at 260 nm. Samples were denatured at 60°C for 10 min in electrophoresis buffer (20 mM
morholinopropane sulfonic acid, 5 mM sodium acetate, 1 mM EDTA, 3% formaldehyde,
pH 7.0) containing 50% formamide. RNA was then size-fractionated by electrophoresing
through 1% agarose gel containing 6% formaldehyde, then transferred to gene screen
filters (New England Nuclear, Boston, MA). Filters were dried, baked at 80°C in vacuo
for 2 b, treated at 42°C for t6-20 h with prehybridization solution (50% formamide,
Denhardt's solution I0.02% Ficoll, 0.02% polyvinylpyrrolidone, 0.02% BSA], 1% SDS, 1
M NaCI, 50 mM Tris HCI, pH 7.4, 250 #g/ml denatured salmon sperm DNA, and
hybridized at 42°C for 24 h in the same solution containing [3ZP]cDNA radiolabeled by
nick translation, or [3~P]IL-2 and [:~eP]IFN oligonucleotides labeled with [32P]ATP and
polynucleotide kinase (17). Filters were washed twice in 2X NaCl/citrate (300 mM NaCI,
30 mM sodium citrate) for 5 min, twice in 2X NaC1/citrate with 1% SDS at 60°C, and
twice at room temperature for 30 rain. Filters were exposed 1-4 d at - 7 0 ° C to Fuji film
using intensifying screens.
Lymphokine Assays. IL-2 activity in conditioned medium was assayed on mouse lyre-
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Results

Stimulus Requirementsfor Optimal Release of Lymphokines. Lectin-primed blood
mononuclear cells proved to be a useful source of T cells for studies of mRNA
levels in stimulated T cells. We first confirmed that the requirements for
lymphokine release from primed cells were similar to those previously reported
for unprimed populations.
Human mononuclear cells were enriched in IL-2-responsive T lymphoblasts
by culturing for 4-5 d in PHA. The cells were washed, restimulated for 16 h
with a number of stimuli singly or in concert, and assayed for IFN and IL-2
release. Little IL-2 release occurred after challenge with PMA, PHA, or the
OKT3 mAb, which reacts with the T3 component of the T cell receptor for
antigen/MHC. Low levels of IFN were induced by PMA or PHA. However, the
mixture of lectin with PMA (Table I) or OKT3 with PMA (data not shown),
were synergistic and induced high levels of lymphokine release. A similar synergism has been reported in studies of iymphokine production by unprimed guinea
pig and human T cells, and the human Jurkat T cell line (2, 20, 21). The
immunosuppressive drug CsA (Table I), but not the inactive analog CsH (not
shown), blocked the release of both IL-2 and IFN from T blasts.
IL-2 also induced low levels of IFN release from T blasts (Table I). This
response could not be attributed to NK cells, as reported for unprimed populations (22, 23), since IFN production was not altered after treatment with antiNK mAb (Leu-7 and Leu-11) and complement (not shown).
The effect of exogenous accessory cells was evaluated. Lectin-primed populations had few monocytes and dendritic cells, as assessed by cytology and by
surface markers; i.e., there were <1% cells stained with the 3C10 antimonocyte
mAb, and <0.1% Ia-rich dendritic cells (24). The primed T cells did not respond
to lectin (Table I), but addition of plastic adherent cells at a ratio of 1:3 restored
the lectin response (not shown). With this background information, we proceeded
to analyze the regulation of lymphokine release at the level of specific mRNAs.

Kinetics of lnduction of Several mRNAs During Optimal Stimulation of Lymphokine
Release. The level of several mRNAs was monitored in primed and unprimed
T cells that were stimulated with lectin and PMA (Figs. 1 and 2). Northern
blotting showed that three mRNAs: actin, /32-microglobulin, and c-myb, were
present in the nonstimulated cells and were not increased by lectin/PMA.
However, six other mRNAs were induced, c-fos mRNA peaked at 0.5 h and
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phoblasts prepared by stimulating spleen cells 3-4 d with Con A (18). Dilutions of medium
(50 ttl) were cultured with 50 ttl of lymphoblasts (4 X 105 cell/ml). After 18-20 h, the
cultures were pulsed with 1.7 ttCi [~H]TdR for 4 h. The uptakes we report are from the
linear portion of the dose-response curve. IFN was determined by RIA (Centocor,
Malvern, PA).
In Vitro Nuclear Transcription Assay. In vitro transcription was performed according
to the method of McKnight and Palmiter (19). Briefly, nuclei (10s) were isolated and used
immediately to prepare nascent RNA transcripts labeled with [s~P]UTP (3,000 Ci/mM;
New England Nuclear) for 30 min at 36°C. The nascent RNA transcripts were purified
by DNase I (RNase free; 50 ttg/ml; Boehringer Mannheim, Houston, TX) treatment,
proteinase K (25 #g/ml; Boehringer Mannheim) digestion, phenol extraction, and ethanol
precipitation. The labeled nuclear RNA was then hybridized to excess specific cDNA (10
ttg) immobilized on nitrocellulose filters. Autoradiographic exposures were 2-4 d.
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TABLE I

Production of lL-2 and IFN-'y upon Restimulation of Human T
Lymphoblasts
IL-2
(cpm [SH]TdR)

IFN--y (U/ml)

None
PHA (1 #g/ml)
PHA + CsA (1 p.g/ml)
PMA (10 ng/ml)
PMA + CsA
PHA + PMA
PHA + PMA + CsA
tiE-2 (300 U/ml)
IL-2 + CsA

937
985
781
2,428
857
122,889
1,307
ND
ND

0
26
0
31
4
144
3
28
20

Conditioned medium (15%) was derived from lympboblasts (10 6 cells]ml)
that had been cultured for 2 h with different stimuli. After 2 h, all stimuli
except IL-2 were removed, and the incubation was continued for 18 h.
IL-2 activity was measured in a bioassay using Con A blasts as responders,
while IFN-~" was measured in an RIA.

quickly disappeared; IL-2, IFN, and c-myc peaked at 3 h in T blasts and at 12 h
in unprimed T cells; and IL-2-R and HSP-70 peaked at 20 h or later. In all
experiments, HSP-70 mRNA was detected in unstimulated cells, but during
mitogenesis, mRNA levels increased several fold. In comparing the responses of
T blasts to unprimed T cells, we noted that: (a) the levels of mRNA per cell
were about fivefo]d higher in the blasts, (b) the IL-2 and IFN responses were
more rapid, and (c) unprimed T cells had baseline c-fos mRNA. We elected in
the next experiments to use lymphoblasts, and we monitored c-fos mRNA levels
at 30 rain, and the other mRNAs at 4-6 h or at 20 h.
Stimuli for Lymphokine and Nonlymphokine mRNas, and Effects of CsA. The
highest levels of IL-2 and IFN mRNAs were induced when lectin and PMA were
added in concert (Fig. 3), just like the release of these lymphokines (Table I).
Lectin or PMA alone induced little or no response in either IL-2 or IFN mRNA.
In contrast, the induction of other genes (c-fos, c-myc, IL-2-R) required only
lectin or PMA, and no synergism was observed (Fig. 3).
The mitogenic OKT3 mAb had no independent effect on any of the mRNAs
we studied, but was markedly synergistic with PMA in inducing IL-2 and IFN
mRNAs (Fig. 4). c-fos, c-myc, and IL-2-R again responded to PMA alone, and
there was no synergism with OKT3.
CsA is known (1-4) to inhibit IL-2 gene transcription, and indeed blocked the
induction of both IL-2 and IFN mRNAs (Figs. 2-4). CsH was not inhibitory
(Fig. 5). CsA also blocked, although not completely, the induction ofc-myc (Figs.
2-4) as was also noted by Reed et al. (25). The addition of CsA for 1 h before
stimulation with lectin or PMA did not lead to a complete block of c-myc
induction. In contrast, CsA did not alter the mRNA levels of other nonlymphokine genes (c-fos, and HSP) in response to either lectin, PMA, OKT3, or
combinations thereof (Figs. 2-4). CsA reduced IL-2-R mRNA levels little (Figs.
2 and 4) or not at all (Fig. 3).
The northern blotting results were pursued with nuclear transcription assays.
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As expected from the prior work of Kronke et al. (26), the induction of IL-2
mRNA by PMA and PHA was at the level of transcription, and was CsA sensitive
(Fig. 6). Increased transcription of c-myc was also apparent and was blocked by
CsA (Fig. 6). We conclude that the induction of lymphokine mRNAs differs
from nonlymphokine mRNAs in the requirement for the concerted action of
PMA and either lectin or OKT3, and in sensitivity to CsA, with the exception
that c-myc is also CsA sensitive.
mRNA Levels in T4 and T8 Subsets. Highly enriched populations of T4+,T8 and T 4 - , T 8 + cells were prepared by panning, and were stimulated with PHA
and PMA in the presence or absence of CsA. IL-2, IFN, and c-myc mRNAs were
induced in both subsets, and the induction was CsA sensitive (Fig. 7).
Effects oflL-2. IL-2 was also evaluated as a stimulus and was found to induce
c-myc, HSP and IL-2-R mRNAs (Fig. 8, left). Peak levels were reached in 5 h,
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FIGURE l. Time course of mRNA accumulation in T lymphoblasts. Human T blasts were
restimulated with 1 /zg/ml PHA and 10 ng/ml PMA for the indicated times (h). Total RNA
was isolated, size fractionated (20/~g for probing with IL-2 and IFN, and 10 vg for the other
genes), and hybridized to szP-labeled probes. Note that all mRNAs except actin are induced,
although the kinetics for each varies. T h e c-fos panel has a background band, just above c-fos
mRNA that was not seen in other blots (see other figures), x, not tested.
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FIGURE 2. Time course of mRNA accumulation in freshly isolated blood mononuclear cells.
T h e celts were stimulated with 1 t~g/ml PHA and 10 ng/ml PMA in the presence or absence
of CsA (1 #g/ml) for the indicated times (h). Total RNA was isolated, size fractionated (70 ug
for probing with IL-2 and IFN, and 10/~g for the others) and hybridized to 3~P-labeled probes.
Note that the kinetics of expression of lymphokine and c-myc genes are slower than those
observed in T blasts (Fig. 1), but again are similar to one another and blocked by CsA.
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and remained elevated for >24 h (not shown). IL-2 was a less effective inducer
than PHA/PMA, but only a fraction of our mononuclear populations (30-50%
of the cells) stained clearly with the anti-TAC mAb against IL-2-R (not shown).
IL-2 induced a small IFN mRNA response, and this induction was not blocked
by CX (Fig. 8, right). IL-2 failed to induce its own mRNA (Fig. 8, right). CsA
did not inhibit any of the responses to IL-2 (Fig. 8). Therefore, IL-2 primarily
stimulates nonlymphokine mRNAs in T cells, and all the responses are CsA
insensitive, including that of c-myc.
Effects of CX. Prior studies had indicated that the protein synthesis inhibitor
CX did not alter lymphokine mRNA levels if applied with the mitogen, but did
block the downregulation of IL-2 mRNA that occurs at later time points (6, 7).
We tested whether CsA interfered with the CX effect. CX did not alter mRNA
levels when given during the first 4 h of mitogen restimulation (Fig. 8, right). If
CX was applied at 4-8 h, both IL-2 and c-myc mRNAs were increased relative
to control, or more precisely, the endogenous downregulation of these mRNAs
did not occur (Fig. 9). HSP and IL-2-R mRNAs were not influenced by CX at
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FIGURE 3. Expression of mRNAs for lymphokine and nonlymphokine genes after PHA and
PMA stimulation; effects of CsA. T blasts were cultured in the presence of PHA (1 #g/ml),
PMA (10 ng/ml), or IL-2 (300 U/ml), with or without CsA (1 #g/ml). After 30 min (c-fos) or
5 h (all other probes), total RNA was extracted, electrophoresed in 1% agarose gel (20 #g
RNA for probing with 1L-2 and IFN; 10 #g for the others), and hybridized with s2P-labeled
probes. Note that IL-2 and 1FN mRNAs require the concerted action of PMA and PHA,
whereas the other mRNAs respond to either stimulus; and CsA blocks the induction of
lymphokine and c-myc mRNAs. A, control; B, PHA; C, PHA + CsA; D, PMA; E, PMA + CsA;
F, PHA + PMA; G, PHA + PMA + CsA; H, IL-2; I, IL-2 + CsA.
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this time (Fig. 9). I f CsA was applied from 4 - 8 h, IL-2 and c-myc m R N A s were
again markedly reduced, but when CX was also present, higher levels o f m R N A
were f o u n d (Fig. 9, right lane). T h e r e f o r e , there appears to be a CX-sensitive
step that develops several hours after T cell stimulation and leads to a lowering
o f IL-2 and c-myc m R N A s . CsA does not seem to inhibit this pathway for increased
lymphokine m R N A .
Discussion
T h e availability o f a large n u m b e r o f D N A probes has made it possible to
m o n i t o r the polyclonal stimulation o f T cells at the level o f several specific
m R N A s . T h e panel we used detected the m R N A s for two lymphokines, IL-2
and IFN, which are major differentiated products o f T cells; three p r o t o o n c o -
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FIGURE 4. Increase in mRNAs after stimulation with OKT3 mAb and PMA; effects of CsA.
Human T lymphoblastswere cultured in the presence of OKT3 (25 ng/ml), PMA (10 ng/ml),
and CsA (1 #g/ml) added singly or in concert. After 30 rain (c-los) or 5 h (all others), total
RNA was extracted (20 t~g of RNA for probing with IL-2 and IFN; 10 gg for the others) and
hybridized with s~P-labeled probes. Note that OKT3 had no effect by itself on mRNA levels,
and that CsA primary altered the induction of lymphokine and c-mycmRNAs.
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FIGURE 6, CsA inhibits c-myc and IL-2 gene transcription. T blasts were cultured in the
presence of PHA (1 ~g/ml) and PMA (10 ng/ml) with or without CsA (1 ug/ml) for 3 h. Nuclei
were isolated and nascent RNA chains labeled with [s~p]UTP. Labeled RNA was hybridized
with 10 ug of denatured c-mycand IL-2 cDNA immobilized on nitrocellulose. Autoradiograms
were developed after 2-4 d.
g e n e s , c-myb, c-myc, a n d c-fos, w h i c h e n c o d e p r o t e i n s t h a t localize to t h e n u c l e u s
a f t e r s t i m u l a t i o n o f m a n y cell t y p e s (10, 32, 34); H S P - 7 0 , p r e v i o u s l y d e t e c t e d in
cells i n f e c t e d with a d e n o v i r u s o r e x p o s e d to h e a t s h o c k (35); a n d I L - 2 - R , w h i c h
is e x p r e s s e d in T cells (26, 36) a n d o t h e r l e u k o c y t e s . T h r e e p a r a m e t e r s w e r e
monitored:
Stimuli. T h e e x p r e s s i o n o f l y m p h o k i n e m R N A s r e q u i r e d d i s t i n c t e x o g e n o u s
stimuli. F o r I L - 2 a n d I F N , o p t i m a l m R N A i n d u c t i o n r e q u i r e d t h e c o n c e r t e d
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FIGURE 5. Lack of an effect of the cyclosporin analog CsH. Human T blasts were cultured
in the presence of PHA (1 ug/ml) and PMA (I 0 ng/ml), with or without CsA or CsH (1 #g/ml)
for 5 h. Serial dilutions of total RNA were applied to nitrocellulose using a BioRad dot blot
apparatus and hybridized with s2p-labeled IL-2 cDNA probe.
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action of PMA and either lectin or O K T 3 mAb (Figs. 3-4). This finding on
primary T cells was similar to that reported for lymphokine mRNA in T cell
lines (2), and for lymphokine secretion (20, 21). There was little and sometimes
no increase in lymphokine mRNA when the T cells were triggered independently
by lectin, PMA, OKT3, or IL-2. In contrast, several nonlymphokine mRNAs:
IL-2-R, c-myc, and c-fos, were induced to high levels by either lectin, PMA, or
IL-2. All these findings seemed to represent direct effects on T cells, since our
populations had few accessory cells by the criteria of direct examination and an
absence of lectin responsiveness (Table I). Furthermore, the responses were
similar in T4 and T8 subsets (Fig. 7).
The requirement for both O K T 3 and PMA during polyclonal activation must
have a counterpart in the physiologic or antigenic stimulation of T cells. The T3
complex is associated with the T cell receptor for antigen and MHC (37), and
binding of O K T 3 mediates a calcium influx (38, 39). One could reason that this
influx, and possibly antigen binding, do not independently lead to lymphokine
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FIGURE 7. Induction of mRNAs in T cell subsets. Human T blasts (taken after 5 d of culture
in lectin) were coated with supernatants from the OKT4 or OKT8 hybridoma lines. The cells
were washed and spun onto Petri dishes coated with affinity-purified Fab2 fragment of goat
anti-mouse Ig. The nonbound cells were harvested and shown to be highly enriched in T4or T8-bearing cells (>95% pure). T h e subsets were stimulated with PHA and PMA with or
without CsA for 5 h. Cytoplasmic RNA was extracted with phenol/chloroform (17), and 10
#g was blotted to nitrocellulose. The filters were hybridized with *2P-labeled probes and
exposed for autoradiography for 3 d. Note that the T cell subsets show similar induction of
IL-2, IFN, c-myc, and HSP, and similar sensitivity to CsA.
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gene expression or to the induction of several genes that are presumably required
for cell division, i.e., comyc, c-fos, and IL-2-R. These findings are reminiscent of
the failure of antigen to independently trigger primary antigen-specific responses
like the mixed leukocyte reaction and T-dependent antibody formation. Instead,
primary stimulation requires that antigen be presented in association with dendritic cells, and the response is accompanied by the initiation of lymphokine
production (40). We are therefore testing whether dendritic cells trigger lymphokine mRNAs in antigen-specific systems to a comparable extent to that seen
with mitogens (OKT3 or PHA) plus PMA.
Kinetics. The application of PMA led to the induction of several genes, but
the kinetics were very different, c-fos appeared early and briefly in stimulated T
cells, as has been observed in other cell types (32, 33). c-myc was expressed shortly
after c-fos, and IL-2-R mRNA appeared much later (Figs. 1 and 2). Whereas the
onset of the PMA response likely involves the activation of protein kinase C, the
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FIGURE 8. Effect o f rlL-2 on the expression o f inducible mRNAs. T blasts were cultured 6
h with 300 U / m l rIL-2 or with P H A (1 ttg/ml) and PMA (10 ng/ml) in the presence or absence
o f 1 ~tg/ml CsA. CX was a d d e d at 5/zg/ml at the onset o f some o f the cultures (right). Note
that IL-2 induces a significant, but CsA-insensitive increase in c-myc, HSP, and IL-2-R m R N A s
(relative to P H A / P M A ; left), whereas 1L-2 has little (IFN) or no (IL-2) effect on lymphokine
m R N A s (right).
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s u b s e q u e n t s t e p s l e a d i n g t o c-fos, c-myc, a n d I L - 2 - R e x p r e s s i o n m u s t d i f f e r to
e x p l a i n s u c h d i f f e r e n t kinetics. E x p r e s s i o n o f I L - 2 a n d I F N m R N A s s e e m s m o r e
r a p i d t h a n e x p r e s s i o n o f I L - 2 - R (Fig. 2). T h i s s u g g e s t s t h a t T cells c a n b e g i n
p r o d u c i n g t h e i r d i f f e r e n t i a t e d p r o d u c t s b e f o r e b e c o m i n g fully c o m p e t e n t f o r
cell g r o w t h . T h e r e f o r e , i m m u n o s u p p r e s s i v e r e g i m e s t h a t a r e d i r e c t e d t o t h e I L -
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FIGURE 9. Effect of CX on the levels of IL-2 and nonlymphokine mRNA. T blasts were
cultured with PHA (1 #g/ml) and PMA (10 ng/ml). CX (10 #g/ml) and/or CsA (1 #g/ml) were
added at the indicated times. Cells were harvested after 4 or 8 h of culture. Total RNA was
extracted, separated in agarose gel, and hybridized with s~p-labeled probes. Note that c-myc
and IL-2 mRNA levels fall between 4 and 8 h (lanes 2 and 3). This decrease is blocked by CX
even in the presence of CsA (lanes 5 and 7).
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Summary
Northern and dot blotting with a panel of DNA probes were used to monitor
the levels of specific mRNAs in mitogen-stimulated human T cells. The induction
of IL-2 and IFN mRNAs required the synergistic action of PMA and either PHA
or OKT3 mAb. In contrast, several nonlymphokine genes, the protooncogenes
c-fos and c-myc, and the IL-2-R gene, were induced by either PHA or PMA alone.
PHA increased the background levels of a 70 kD heat shock protein mRNA, but
did not affect the observed background of c-myb mRNA. For all mRNAs that
were induced, isolated CD4 and CD8 T cell subsets behaved similarly. Exogenous
IL-2 had little (IFN) or no (IL-2) effect on lymphokine mRNAs, but significantly
increased c-myc, IL-2-R and heat shock protein mRNAs. Therefore, the stimuli
for lymphokine mRNAs differed from those required for several inducible
nonlymphokine genes.
IL-2 and IFN mRNAs exhibited some important similarities with c-myc, however. The levels of IL-2, IFN, and c-myc mRNA followed similar kinetics, peaking
at 3 h in restimulated blasts and at 12 h in unstimulated T cells. The subsequent
downregulation of iymphokine and c-myc mRN As was retarded by cycloheximide.
The induction of IL-2, IFN, and c-myc mRNAs was blocked by the immunosuppressive drug CsA, but not by the inactive analog CsH, and this block occurred
at the level of nuclear transcription. Since the exogenous stimuli for lymphokine
and c-myc gene expression differ, we suggest that intracellular controls must be
shared to account for the similarities in their kinetics of expression and CsA
sensitivity.
We thank Heidi Gemperle for her excellent technical assistance; Dr. P. Barr for the IL-2
and IFN-3, oligonucleotide probes; Drs. J. F. Borel, B. Ryffel, V. Quesniaux for the gift
of CSA and CSH; Dr. D. Foster and H. Hanafusa for providing c-fos and c-myb cDNA;
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2-R, such as application of anti-IL-2-R antibodies, may not efficiently ablate T
cell function, since lymphokines could still be formed.
CsA. The profound immunosuppressive effects of CsA on T cells are well
known, but it is only recently that a selective effect on lymphokine mRNA has
been stressed (1-4). An exception appears to be the c-myc gene, which is believed
to encode a nuclear binding protein, and which can be induced in many cell
types (41). We are testing whether CsA will block c-myc expression in non-T
cells, since this could lead to nonspecificity in its clinical action.
The sensitivity of c-myc to CsA is most useful in analyzing the mechanism of
action of this drug. It is difficult to argue that CsA blocks signalling at the cell
surface, since it is apparent that CsA blocks the c-myc response to PMA or lectin,
but not the response of other genes (c-fos, IL-2-R) to PMA or to lectin. CsA also
does not block the IL-2-induced increase in c-myc mRNA, or the smaller increase
in IFN mRNA. The fact that c-myc and lymphokine mRNAs also exhibited
similar kinetics prompts our working hypothesis that CsA acts on a transcriptional
control site that is shared by lymphokine and c-myc genes, either by binding
directly to this region or by inhibiting the function of a control factor acting
thereon.
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Pure for reviewing the manuscript.

Received for publication 17 December 1985.

Downloaded from https://rupress.org/jem/article-pdf/163/4/922/484720/922.pdf by Rockefeller University user on 20 July 2020

References
1. Granelli-Piperno, A., K. Inaba, and R. M. Steinman. 1984. Stimulation oflymphokine
release from T lymphoblasts. Requirement for mRNA synthesis and inhibition by
cyclosporin A.J. Exp. Med. 160:1792.
2. Wiskocil, R., A. Weiss, J. lmboden, R. Kamin-Lewis, and J. Stobo. 1985. Activation
of a human T cell line: A two-stimulus requirement in the pretranslational events
involved in the coordinate expression of interleukin 2 and y-interferon genes. J.
Immunol. 134:1599.
3. Kronke, M., W.J. Leonard, J. M. Depper, S. K. Arya, F. Wong-Staal, R. C. Gallo,
T. A. Waldman, and W. C. Greene. 1984. Cyclosporin A inhibits T-cell growth
factor gene expression at the level of mRNA transcription. Proc. Natl, Acad. Sci. USA.
81:5214.
4. Elliott, J. F., Y. Lin, S. B. Mizel, R. C. Bleackley, D. G. Harnish, and V. Paetkau.
1984. Induction of interleukin 2 messenger RNA inhibited by Cyclosporin A. Science
(Wash. DC). 226:1439.
5. Hirano, T., K. Fujimoto, T. Teranishi, N. Nishino, K. Onoue, S. Maeda, and K.
Shimada. 1984. Phorbol ester increases the level of interleukin 2 mRNA in mitogenstimulated human lymphocytes. J. Immunol. 132:2165.
6. Efrat, S., and R. Kaempfer. 1984. Control of biologically active interleukin 2
messenger RNA formation in induced human lymphocytes. Proc. Natl. Acad. Sci.
USA. 81:2601.
7. Efrat, S., and R. Kaempfer. 1985. Regulation of human interleukin-2 gene expression.
J. Leukocyte Biol. 38:49a (Abstr.).
8. Clark, S. C., S. K. Arya, F. Wong-Staal, M. Matsumoto-Kobayashi, R. M. Kay, R. J.
Kaufman, E. L. Brown, C. Shoemaker, T. Copeland, S. Oroszlan, K. Smith, M. G.
Sarngadharan, S. G. Linder, and R. C. Gallo. 1984. Human T-cell growth factor:
partial amino acid sequence, cDNA cloning, and organization and expression in
normal and leukemic ceils. Proc. Natl. Acad. Sci. USA. 81:2543.
9. Curran, T., G. Peters, C. Van Beveren, N. M. Teich, and I. M. Verma. 1982. FBJ
Murine osteosarcoma virus: identification and molecular cloning of biologically active
proviral DNA.J. Virol. 44:674.
10. Stanton, L. W., R. Watt, and K. B. Marcu. 1983. Translocation, breakage on
truncated transcripts of c-myc oncogene in murine plasmacytomas. Nature (Lond.).
303:401.
11. Klempnauer, K. H., T. J. Gonda, and J. M. Bishop. 1982. Nucleotide sequence of
the retroviral leukemia gene v-myb and its cellular progenitor c-myb: The architecture
of a transduced oncogene. Cell. 31:453.
12. Leonard, W. J., J. M. Depper, G. R. Crabtree, S. Rudikoff, J. Pumphrey, R.J. Robb,
M. Kronke, P. B. Svetlik, N.J. Peffer, T. A. Waldmann, and W. C. Greene. 1984.
Molecular cloning and expression of cDNAs for the human interleukin 2 receptor.
Nature (Lond.) 311:626.
13. Cleveland, D. W., M. A. Lopata, R.J. MacDonald, N.J. Cowan, W.J. Rutter, and
M. W. Kirschner. 1980. Number and evolutionary conservation of a- and fl-tubulin
and cytoplasmic fl- and ~,-actin genes using specific cloned cDNA probes. Cell. 20:95.
14. Parnes, J. R., B. Velan, A. Felsenfeld, L. Ramanathan, U. Ferrini, E. Appella, and J.
C. Seidman. 1981. Mouse fl2-microglobulin cDNA clones: a screening procedure for
cDNA clones corresponding to rare mRNAs. Proc. Natl. Acad. Sci. USA. 78:2253.

936

CONTROL OF LYMPHOKINE mRNA LEVELS

Downloaded from https://rupress.org/jem/article-pdf/163/4/922/484720/922.pdf by Rockefeller University user on 20 July 2020

15. Chirgwin, J. M., A. E. Przybyla, R. J. MacDonald, and W.J. Rutter. 1979. Isolation
of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 18:5294.
16. Glisin, V., R. Crvenjakav, and C. Byus. 1974. Ribonucleic acid isolated by cesium
chloride centrifugation. Biochemistry. 13:2633.
17. Maniatis, T., E. F. Fritsch, and J. Sambrook. 1982. Molecular cloning: A Laboratory
Manual. Cold Spring Harbor Laboratory Press. Cold Spring Harbor, NY
t 8. Granelli-Piperno, A., J. D. Vassalli, and E. Reich. 1981. Purification of murine T-cell
growth factor. A lymphocyte mitogen with helper activity.J. Exp. Meal. 154:422.
19. McKnight, G. S., and R. Palmiter. 1979. Transcriptional regulation of the ovalbumin
and conalbumin genes by steroid hormones in chick oviduct.J. Biol. Chem. 254:9050.
20. Rosenstreich, D. L., and S. B. Mizel. 1973. Signal requirements for T lymphocyte
activation. I. Replacement of macrophage function with phorbol myristic acetate. J.
lmmunol. 123:1749.
21. Hara, T., and S. M. Fu. 1985. Human T cell activation. I. Monocyte-independent
activation and proliferation induced by anti-T3 monoclonal antibodies in the presence
of tumor promotor 12-0-tetradecanoyl phorbol- 13-acetate. J. Exp. Med. 161:641.
22. Trinchieri, G., M. Matsumoto-Kobayashi, S. C. Clark, J. Seehra, L. London, and B.
Perussia. 1984. Response of resting human peripheral blood natural killer cells to
interleukin 2.J. Exp. Med. 160:1147.
23. Handa, K., R. Suzuki, H. Matsui, Y. Shimizu, and K. Kumagai. 1983. Natural killer
(NK) cells as responder to interleukin (IL-2) II. IL-2 induced interferon gamma
production. J. lmmunol. 130:988.
24. Van Voorhis, W. C., R. M. Steinman, L. S. Hair, J. Luban, M. D. Witmer, S. Koide,
and Z. A. Cohn. 1983. Specific antimononuclear phagocyte monoclonal antibodies.
J. Exp. Med. 158:126.
25. Reed, J. C., P. C. Nowell, and R. G. Hoover. 1985. Regulation ofc-myc mRNA levels
in normal human lymphocytes by modulators of cell proliferation. Proc. Natl. Acad.
Sci. USA. 82:4221.
26. Kronke, M., W. J. Leonard, J. M. Depper, and W. C. Greene. 1985. Sequential
expression of genes involved in human T lymphocyte growth and differentiation. J.
Exp. Med. 161:1593.
27. Bernard, O., S. Cory, S. Gerondakis, E. Webb, andJ. M. Adams. 1983. Sequence of
the murine and human cellular c-myc oncogenes and two modes of myc transcription
resulting from chromosome translocation in B lymphoid tumors. EMBO (Eur. Mol.
Biol. Organ.)J. 2:2375.
28. Holbrook, N.J., K. A. Smith, A.J. Fornace, Jr., c. M. Comeau, R. L. Wiskocil, and
G. R. Crabtree. 1984. T-cell growth factor complete nucleotide sequence and
organization of the gene in normal and malignant ceils. Proc. Natl. Acad. Sci. USA.
81:1634.
29. Gray, P. W., and D. W. Goeddel. 1982. Structure of the immune interferon gene.
Nature (Lond.). 298:859.
30. Fujita, T., C. Takoaka, H. Matsui, and T. Taniguchi. 1983. Structure of the human
interleukin 2 gene. Proc. Natl. Acad. Sci. USA. 80:7437.
31. Mira, S., S. Maeda, K. Obaru, N. Nishino, K. Shimada, T. Hirano, K. Onoue, T.
Ogawa, and H. Ogawa. 1983. Isolation and characterization of a human interleukin
2 gene. Biochem. Biophys. Res. Commun. 117:114.
32. Muller, R., R. Bravo, J. Burckhardt, and T. Curran. 1984. Induction of c-fos gene
and protein by growth factors precedes activation of c-myc. Nature (Lond.). 312:716.
33. Greenberg, M. E., and E. B. Ziff. 1984. Stimulation of 3T3 cells induces transcription
of the c-fos proto-oncogene. Nature (Lond.). 311:433.
34. Kelly, K., B. H. Cochran, C. D. Stiles, and P. Leder. 1983. Cell-specific regulation of

GRANELLI-PIPERNO ET AL.

35.
36.
37.

39.
40.
41.

the c-myc gene by lymphocyte mitogens and platelet-derived growth factor. Cell.
35:603.
Kao, H. T., andJ. R. Nevins. 1983. Transcriptional activation and subsequent control
of the human heat shock gene during adenovirus infection. Mol. Cell Biol. 3:2058.
Depper, J. M., W. J. Leonard, C. Drogule, M. Kronke, T. A. Waidmann, and W. C.
Greene. 1985. Interleukin 2 (IL-2) augments transcription of the IL-2 receptor gene.
Proc. Natl. Acad.. Sci. USA. 82:4230.
Meuer, S., O. Acuto, R. E. Hussey, J. Hodgdon, K. A. Fitzgerald, S. F. Schlossman,
and E. L. Reinherz. 1983. Evidence for the T3-associated 90 kD heterodimer as the
T cell antigen receptor. Nature (Lond.). 303:808.
Weiss, A.,J. lmboden, D. Shobach, andJ. Stobo. 1984. Role o f T 3 surface molecules
in human T-cell activation: T3-dependent activation results in an increase in cytoplasmic free calcium. Proc. Natl. Acad. Sci. USA. 81:4169.
Oettgen, H. C., C, Terhorst, L.. C. Cantley, and P. M. Rosoff. 1985. Stimulation of
the T3-T cell receptor complex induces a membrane-potential sensitive calcium
influx. Cell. 40:583.
Inaba, K., and R. M. Steinman. 1984. Resting and sensitized T lymphocytes exhibit
distinct stimulatory (antigen presenting cell) requirements for growth and lymphokine
release.J. Exp. Med. 160:1717.
Ramsay, G., G. I. Evans, andJ. M. Bishop. 1984. The protein encoded by the human
proto-oncogene c-myc. Proc. Natl. Acad. Sci. USA. 81:7742.

Downloaded from https://rupress.org/jem/article-pdf/163/4/922/484720/922.pdf by Rockefeller University user on 20 July 2020

38.

937

